KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Notes Payables (2018 - 2024)

Exact Sciences (EXAS) has disclosed Notes Payables for 5 consecutive years, with $249.2 million as the latest value for Q4 2024.

  • Quarterly Notes Payables changed N/A to $249.2 million in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $249.2 million through Dec 2024, changed N/A year-over-year, with the annual reading at $249.2 million for FY2024, N/A changed from the prior year.
  • Notes Payables for Q4 2024 was $249.2 million at Exact Sciences, roughly flat from $249.0 million in the prior quarter.
  • The five-year high for Notes Payables was $313.1 million in Q3 2021, with the low at $1.3 million in Q2 2020.
  • Average Notes Payables over 3 years is $150.2 million, with a median of $248.8 million recorded in 2024.
  • Peak annual rise in Notes Payables hit 23637.98% in 2021, while the deepest fall reached 94.63% in 2021.
  • Over 3 years, Notes Payables stood at $1.3 million in 2020, then surged by 23637.98% to $313.1 million in 2021, then fell by 20.42% to $249.2 million in 2024.
  • According to Business Quant data, Notes Payables over the past three periods came in at $249.2 million, $249.0 million, and $248.9 million for Q4 2024, Q3 2024, and Q2 2024 respectively.